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Background: It is believed that the main factors of low prenatal growth in mammals are genetic and
environmental. We used isogenic mice maintained in standard conditions to analyze how natural non-genetic
microsomia (low birth weight) is produced in inbred mice and its long term effect on health. To better understand
the molecular basis of non-genetic microsomia, we undertook transcriptome profiling of both male and female
livers from small and normal size mice at birth.
Results: Naturally occurring neonatal microsomia was defined as a gender-specific weanling weight under the 10th
percentile of the colony. Birth weight variation was similar in inbred and outbred lines. Mice were phenotyped by
weight, size, blood pressure, organ size, their response to a glucose challenge, and survival rates. Regardless of diet,
adult mice born with microsomia showed a significantly lower body weight and size, and differences in the weight
of several organs of microsomic adult mice compared to normal birth weight adults were found. After a high-fat
diet, microsomic mice were less prone to obesity, showing a better glucose tolerance and lower blood pressure.
Through a transcriptome analysis, we detected a different pattern of mRNA transcription in the liver at birth comparing
male vs female and microsomic vs normal mice, noting some modifications in epigenetic regulatory genes in females
and modifications in some growth factor genes in males. Finally, using embryo transfer of embryos of different quality
and age, we identified a putative preimplantation origin of this non-genetic microsomia.
Conclusions: (1) neonatal microsomia is not always a risk factor for adult metabolic syndrome, (2) neonatal non-genetic
microsomia displays changes in the expression of important epigenetic genes and changes in liver mRNA transcription
profile at birth, exaggerating sexual dimorphism, and (3) random preimplantation phenotypic variability could partially
explain body birth weight variation in isogenic lines.
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Human Intrauterine Growth Restriction (IUGR) causes a
reduction of fetal growth rate and frequently derives into
low birth weight [1]. Worldwide, more than 20 million
children suffer this last syndrome, representing a global
prevalence of 15.5%, from which 95% occurs in low and
middle income countries (LMICs). Birth weight is widely
accepted as a prognosis factor of fetal and neonatal* Correspondence: a.mirandabedate@uu.nl; agutierr@inia.es
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unless otherwise stated.health [2] but although not all low values for this fea-
ture are pathological, it is mostly associated to IUGR
in LMICs [3]. As a consequence, it seems to produce a
higher risk of neonatal and perinatal mortality, aging
metabolic diseases and neurocognitive disorders [4-6].
In most polytocous species, each newborn in a litter
will differ in size and weight. However, random variation
in these measurable biological traits is not remarkably
diminished by reducing genetic variation using inbred
strains or reducing environmental variability through
standardized husbandry in laboratory animals. It is
propose that processes during early embryogenesis mayl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ity, age of sow and season at conception were observed
to only explain 20% of within-litter variation in piglets
birth weight, meanwhile factors such as embryo geno-
type or epigenetics that affect embryo and fetus develop-
ment would be responsible of most of heterogeneity [8].
Moreover, pathological low birth weight has been correlated
with a risk of metabolic syndrome (diabetes, hypertension
and obesity in adulthood) [(Developmental Origins of
Health and Disease (DOHaD)] [9-13] and most DOHaD
studies have used birth weight as an entry criterion to ex-
plore its long term effects. However, to date there is scarce
evidence to suggest that naturally (non-genetic) occurring
low birth weight may have a negative long term effect, and
we lack data on the subsequent characteristics developed
by each sex.
In the current study, we examined natural birth weight
variations in inbred mice (homozygous at every allele) to
determine how a single genotype in a similar environ-
ment may give rise to different phenotypes at birth.
Microsomia was concretely assessed, which is present
in those individuals with weight at birth below the 10th
percentile of the colony. We also analyzed the mecha-
nisms that give rise to the phenotypic changes of these
naturally produced small mice and compared the transcrip-
tional profile of the liver at birth in normal, microsomic (M)
male and M female mice. Any observed phenotypic differ-
ences among these inbred mice are mostly epigenetic be-
cause, by definition, genetic variation has been eliminated
and environmental changes have been reduced. Although
the underlying mechanisms of fetal programing are still un-
known, epigenetics has been suggested as one of the pos-
sible explanations for links observed between intrauterine
risk factors and metabolic syndrome development. The
mechanisms whereby an event that occurs early in life
may have long term effects on the phenotype of an or-
ganism many years later are only now starting to emerge
[14-17]. Understanding such processes will help to developFigure 1 No differences were observed in birth weight variation in m
plot indicating mean ± SD (box) and mean ± 1.96 SD (lines). (B) Comparing
of birth weight in six groups of mice: naturally born male and female B6 mic
in vivo produced Day 3 morulas (M3) and five Day 4 blastocysts (B4) (mi
in vivo produced Day 4 morulas (M4) and five Day 4 blastocysts (B4) (bopreventive and treatment strategies for common diseases
such as type 2-diabetes or cardiovascular disease.
Results
Microsomic growth adaptation in newborn inbred mice
C57BL/6 N and CD-1 males and females were mated
under conditions of standardized husbandry and individ-
uals from the resulting litters were measured at birth.
About 10% of the newborn animals were significantly
smaller and weighed less (below the 10th percentile for
the colony weanling weight) than genetically identical
animals in the same litter. This suggests an intrauterine
factor-driven growth alteration or the normal conse-
quence of random phenotypic variability. No differences
were detected in the mean standard deviations of birth
weights recorded for 20 litters of outbred (CD1) versus
inbred line (C57BL/6 N) (Figure 1A). At weaning, the M
mice also weighed significantly less than their litter sib-
lings (p < 0.01) (Figure 2A and 2B).
To examine the phenotypic response to a high-fat diet
(hfd), mice were fed a normal diet (C) or a diet rich in
lipids from weeks 6 to 24 of age (C + hfd). At the end of
this period, significant weight and size differences were ob-
served between the M and the control normal birth weight
animals, regardless of sex and diet (p < 0.05) (Figure 2).
However, these differences were significantly more pro-
nounced throughout the entire life span of the mice in ani-
mals receiving the high-fat diet (p < 0.01). In order to
assess anatomical variations derived from both diet and
corporal condition (M or C), weight of 90 weeks old mice
as well as their organs were recorded (Additional file 1:
Table S1). Interestingly, liver, which plays an important role
in metabolism and thus in the potential hfd outcome,
didn’t show any significant variation between M and C
mice for both diets, regardless of sex. Several differences
were found in other organs, however they lacked apparent
correlation with the considered conditions. These results
suggest a metabolic regulation pathway present in the Male and female CD1 outbred vs B6 inbred mice. (A) Box-Whisker
the full range of random phenotypic variability (4× coefficient of variation)
e (top lines), mice born after the simultaneous transfer of five
ddle lines) and mice born after the simultaneous transfer of five
ttom lines).
Figure 2 Microsomic animals are reduced in size and weight and more resistant to obesity than control animals. Body weights recorded
over an 80-week period in M and C males (A) and females (B) fed a normal or high-fat diet (hfd) for 18 weeks (from weeks 6 to 24 of age). Body
lengths recorded for M and C males (C) and females (D) at 30-33 weeks of age following 18 weeks of a normal or hfd (*P < 0.05. Error bars, s.e.m.).
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trol mice when given a diet rich in lipids. Moreover, unlike
controls, M male mice on high-fat diet for 18 weeks recov-
ered a similar weight to that of M not given a high-fat diet.
The lack of catch-up growth in our mice model (Figure 2)
indicates the animals had not suffered nutrient restriction
since at the time of weaning and well into adulthood,
microsomic mice were always lighter in weight and shorter
in length.
In order to assess the presence of metabolic syndrome,
a glucose tolerance test and systolic blood pressure
(SBP) measurements were performed at 6 months of
age, a life span in which mice are considered to have
reached the adult age. When subjected to a glucose tol-
erance test, M mice recovered normal glucose levels fas-
ter than controls (Figure 3A and 3C). Moreover, the area
under curve (AUC) was significantly reduced for both
diet groups of animals (Figure 3B and 3D), suggesting an
adaptive response of glucose levels in M animals. Similar
results were recorded in SBP irrespective of diet althoughdifferences were greater for M males than M females rela-
tive to their respective controls (Figure 3E and F).
Both M and C mice were maintained for 2 years to as-
sess the possible appearance of any disorders with a late
age of onset. However, no differences in age-related
pathologies were seen between C and M mice. Figure 3G
and 3H shows survival rates in males and females of
control (C) and microsomic (M) mice fed with both nor-
mal diet and lipid rich diet during 24 weeks (hfd). Sur-
vival rate of C and M animals was similarly high for
both genders (range 70-80% at 24 months) while C +
hfd mice have a significant decrease in comparison
with M + hfd mice. Both groups fed with hfd have a
significant decrease on the survival rates in compari-
son with normal diet.
To determine whether birth weight variation originates
during the preimplantation or fetal period, birth weight var-
iations were compared after the simultaneous transfer of
in vivo produced good quality embryos (IETS grade 1) of
different age and developmental stage (50% Day 3 morulas
Figure 3 Microsomic animals recover faster from a glucose challenge and show a lower systolic blood pressure (SBP) than control
animals. Glucose tolerance test performed in M and C male mice fed with a normal (A) or a high-fat diet (hfd) for 18 weeks (C). Area under the
curve (AUC) for the glucose tolerance test performed in M and C mice fed with normal (B) or high-fat diet (hfd) for 18 weeks (D) (*P < 0.05. Error
bars, s.e.m.). SBP recorded in M and C males (E) and females (F) fed with a normal or hfd for 18 weeks, respectively. [a, b] indicate a significant
difference at P < 0.05. Error bars, s.e.m. Survival rate in M and C male (G) and female (H) fed with or without hfd, respectively.
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of in vivo produced embryos (without selecting good qual-
ity embryos) of the same age (Day 4) but different develop-
mental stage (common in mice) (50% blastocysts and 50%
morulas). Birth rates were 81% versus 57% in first and sec-
ond experiments respectively. Thus, the rate was reduced
when embryos of different quality were transferred. After
weighing mice from 12 litters for both experiments, we ob-
served that only the transfer of embryos of the same age
though different developmental stage gave rise to a higher
coefficient of variation [(standard deviation/mean)/100] inbody weight at birth (Figure 1B), and that the transfer of se-
lected good quality embryos comprising 3-day-old morulas
and 4-day-old blastocysts led to reduced birth weight varia-
tions, suggesting the preimplantation origin of this alterna-
tive developmental program.
Microarray analysis: overall results and validation
To evaluate gene expression variations in normal and M
animals, a microarray analysis of liver from newborns
was performed. Liver was selected since it is one of the
relatively more homogeneous organs that can suffer the
Table 1 Validation of array data by real-time qRT-PCR
analysis (expression fold changes)
Female microsomic vs control Male microsomic vs control
Gene qPCR Array Gene qPCR Array
Smarcc1 11.32 10.81 Crabp2 13.97 15.05
Ruvbl2 6.30 5.14 Chd1 2.09 1.99
Hdac5 3.65 3.72 Vegfa -2.34 -1.94
Trim28 2.03 2.35 Fgf23 -2.09 -2.37
Irs2 2.45 2.17
Gata-1 -2.91 -2.07
Igf1 -2.60 -2.37
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the effects of a putative developmental malnutrition that
could lead to microsomia would have certain transcrip-
tional effects in this organ, since it is an important step
in nutrient metabolism and detoxification. Moreover, the
absence of significant liver weight variation due to the
common fat accumulation in the hfd group supported
the possibility of gene expression changes in order to
prevent it. Hence, liver is one of the best candidates to
assess whether this phenotype has an intrauterine envir-
onmental origin. The Mouse Agilent microarray system
used covers 39,430 unique genes and 16,241 lincRNAs.
Twelve expression datasets (3 independent experiments
using liver tissue from normal –control– males/females
and M males/females mice respectively) were obtained
and the following calculations were performed according
to the GeneSpring GX (Agilent Technologies) manufac-
turer’s instructions. After selecting genes according to
their P-value (limma; t-test) of significance (P <0.01),
these genes were further filtered to remove those whose
expression was below a threshold, based on median nor-
malized intensity values, which was considered to be the
no-change threshold (fold change >1.5). Four pairwise
comparisons were performed: 1) control (C) males vs M
males; 2) C females vs M females; 3) C males vs C fe-
males; and 4) M males vs M females.
In total, 776 differentially expressed genes (DEGs) were
detected for M vs C females, most of which were upregu-
lated in M females (525 vs 251) (Additional file 2: Figure
S1). For M vs C males, we detected 437 DEGs, also mostly
upregulated in the M group (330 vs 107), suggesting a
more complex regulation in females (Additional file 2:
Figure S1). Some DEGs were common to M mice
groups, such as the epigenetic regulator Trim28, which
was upregulated in M females while downregulated in
M males in comparison to their respective controls.
The Pbx1 and retinoic acid pathway genes (Ppar, Rbp3,
Crabp-II and RxR) were also differentially expressed in the
two experimental comparisons, with M animals showing
greater expression in both comparisons. Further import-
ant DEGs such as Chd1 and Ncor1 were specifically up-
regulated in M males compared to C group and Hdac5,
Igf-1, Tgfb1 and c-Met were upregulated in M females
compared to C mice.
To validate the array results, 11 genes were chosen
for RT-PCR analysis in independent samples: three
pluripotency related genes (POU5F1, SOX2, NANOG),
two trophectodermal markers (KRT18, CDX2), one
gene associated with DNA methylation (DNMT3B),
one gene involved in polyamine biosynthesis (ODC1),
and four genes related to nutrient homeostasis (RGN,
STC2, SLC6A6, SLC7A1). No differences were ob-
served between the real time PCR and array results
(Table 1).Gene ontology
The gene ontology classification system (FatiGo) was used
after enrichment score (ES) analysis (ES ≥ 1.3) to classify
genes according to biological function and corresponding
cell components [19]. For M vs C males, genes involved in
translation and steroid metabolic process were upregu-
lated in mice with microsomia while transcription regulat-
ing genes were downregulated. Golgi apparatus and
ribosomal genes were upregulated while nuclear genes
were downregulated (Additional file 3: Figure S2). For
M vs C females, genes involved in the processes cell
proliferation, transcription regulation, tissue morpho-
genesis, gland morphogenesis and skeletal system de-
velopment were upregulated while purine metabolism,
pyrimidine metabolism, mRNA processing, M phase
cell division and condensed chromosome were down-
regulated. Nuclear and cytoplasm genes were upregu-
lated while ribonucleoprotein complex, chromosome and
non-membrane-bound organelle genes were downregu-
lated (Additional file 4: Figure S3). The results of compar-
ing C males vs C females with M males vs M females are
indicated in (Additional file 5: Figure S4 and 6: Figure S5).
Discussion
In this work, we report an inbred mouse model of natur-
ally occurring low birth weight, of non-genetic origin,
and with no detrimental long term effects. The low birth
weight produced at parturition is here ascribed to nat-
ural preimplantation developmental variability. Interest-
ingly, newborn male and female mice with M increased
differentially their weight in response to a high-fat diet.
This particular feature of M mice contrasts with the long
term negative effects of a low birth weight observed in
other studies on small animals addressing the DOHaD
theory [20-22]. In addition, we noted that M animals re-
ceiving a high-fat diet were more resistant to acquiring
an overweight phenotype and have higher survival rates
than controls. Curiously, liver didn’t undergo weight
changes due to fat accumulation, a feature which is
relatively common in certain types of hfd [23-26].
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be happening that could explain this feature. More-
over, the different metabolic programs detected with
respect to genetically identical littermates suggest epi-
genetic alterations in these M animals. Differential total
weight gain was also observed when considering sex,
indicating a divergent physiological mechanism between
males and females [13,27-29]. This observation was con-
firmed by gene ontology analysis. Indeed, in M males, only
a few post-transcriptional modifications and enrichment
in metabolic genes and the corresponding organelles
(ribosomes and Golgi apparatus) were observed, sug-
gesting protein-based adaptation. In contrast, a larger
number of processes were overrepresented in M females,
highlighted by nuclear gene enrichment and the downreg-
ulation of chromosome condensation.
To better understand the molecular basis of non-
genetic microsomia, a microarray experiment was con-
ducted on the liver of newborns. Microsomic females
showed a significantly higher number of DEGs than M
males compared with their respective controls (776 vs
437), supporting more complex metabolic changes in fe-
males. Among the DEGs detected, the important epigen-
etic regulator Trim28 (tripartite motif-containing 28) was
found in both sexes. Also known as Kap1 (KRAB-associated
protein-1), the gene Trim28 is ubiquitously expressed
throughout development [30] and is a critical regulator
of this process. Some authors have attributed to this
protein an important role in epigenetic control whereby it
physically attaches itself to several histone methyltransfer-
ases (HMTs) [31], synergistically triggering the methyla-
tion of transposons [32]. In MF, Trim28 was upregulated
along with Hdac5 (Additional file 7: Table S2) compared
to CF, which suggests a change in the epigenome as theFigure 4 Suggested model and summary of epigenetic changes poss
circles: Downregulated genes ( : activation; : inhibition; : protmechanism for the alternative metabolic program. This
observation is consistent with the findings reported by an-
other study in which epigenetic changes in histones in-
duced by a Trim28 heterozygous deletion were linked to
weight variations at birth [33]. This latter study also re-
vealed a high predisposition of female Trim28 heterozy-
gous mice to impaired glucose tolerance. Moreover, we
have observed in a previous work persistent epigenetic
changes and glucose intolerance phenotypes in animals
born after embryo in vitro culture, including M animals
showing improved glucose tolerance over controls [34]. A
more efficient use of glucose could therefore explain why
the M animals in the present study weighed less during
the whole experiment, regardless of sex or diet.
Ingenuity Pathway Analysis of deregulated genes re-
vealed that epigenetic-mediated Trim28 upregulation in
MF mice could lead to the upregulation of several markers
that could explain this phenotype (Figure 4) such as Igf-1
(insulin growth factor-1) and c-Met proto-oncogene. Igf-1
has been identified as an important factor for developmen-
tal growth [35]. Our results for MF indicated the overex-
pression of this gene in offspring compared with controls
(Additional file 7: Table S2). These data are in line with
published results, whereby elevated hepatic Igf-1 mRNA
and plasma IGF-1 levels were attributed to an attempt to
compensate for a reduced hepatic and body size at birth
[36]. Moreover, this marker has been also related to epi-
genetic modifications in H3K4 histone [36], thereby sup-
porting our hypothesis of this type of modification in our
model.
The proto-oncogene c-MET is a transmembrane tyro-
sine kinase cell surface receptor for hepatocyte growth
factor (HGF), which is mainly involved in cell prolifera-
tion and tumor expansion [37,38]. In the liver, c-METibly occurring in MF vs CF. Green circles: upregulated genes; Red
ein complex).
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to its plasticity [39], thus the high expression levels ob-
served for this gene in MF (Additional file 7: Table S2)
could be attributed to an adaptation process. This find-
ing together with the fact that no c-Met transcription
variation was detected in microsomic males, could sup-
port the idea of a more complex adaptation process in
females. Importantly, this gene has also been associated
with skeletal muscle atrophy in mice [40], providing an
alternative explanation for the low weight shown by
these animals at birth. In addition, c-MET has been re-
cently related to the capacity of the liver to regulate
blood glucose levels, inducing hepatic uptake and inhi-
biting output [41]. Thus, the lower AUC obtained in the
glucose tolerance test could be explained by the syner-
gistic reduction of blood glucose and IGF-1 levels.
Curiously and contrary to the case in females,Trim28 was
downregulated in M males compared with Cs (Additional
file 7: Table S2). Chd1 (chromatin remodeling factor-1) was
also found to be upregulated as were other components of
this epigenetic protein complex, namely Ncor1 (nuclear
receptor corepressor-1) and Pbx1 (pre B-cell leukemia
homeobox-1) (Additional file 7: Table S2). CHD1 is a
helicase DNA binding protein required to maintain the
open chromatin of pluripotent mouse embryonic stem
cells [42]. This protein associates with the promoters
of active genes to maintain the current transcriptionalFigure 5 Suggested model and summary of expression changes in th
circles: upregulated genes; White circles: No change in expression ( : acprofile [42] in response to epigenetic changes such as
methylations [43]. In the same line, NCoR1 co-repressor
protein has been identified in histone-deacetylase (HDAC)
complexes with a role in chromatin structure modulation
[44], and PBX1 has been described to regulate the activity
of the epigenetic coactivators HDACs and histone acetyl-
transferases [45]. These data again support the hypothesis
of epigenetic alterations provoking the altered gene ex-
pression profile of microsomic animals.
Ingenuity Pathway Analysis of deregulated genes indi-
cated that some members of the retinoic acid (RA) canon-
ical pathway were upregulated in microsomic animals of
both sexes (Additional file 7: Table S2) (Figure 5) in com-
parison to their respective controls (C male and C female).
Several early studies revealed that nuclear receptors such
as retinoid X receptors (RXR) and thyroid hormone recep-
tor (TR), translocate to the nucleus and associate with nu-
clear corepressors such as NCoR1 or NCoR2 (or SMRT,
silencing mediator for retinoid and thyroid hormone re-
ceptors) [46,47]. As mentioned before, these nuclear recep-
tors recruit HDAC, resulting in histone deacetylation,
chromatin compaction, and silencing of target gene expres-
sion [44,48]. Hence, in the case of M males, the RA path-
way could be mediating the epigenetic changes needed
for the correct adaptation to intrauterine environment
variations in collaboration with the upregulated NCoR1.
Interestingly, numerous research efforts have revealed ae RA pathway possibly occurring in microsomic animals. Green
tivation.
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HOX-PBX1 during certain stages of development [49]. Al-
though interactions of the HOX-PBX1 system with DNA
were found to be dispensable for RA to control the tran-
scription profile [50], a possible role of PBX1 in regulating
imprinted genes is supported by the present findings.
Thus, in our model of M males, it could be that PBX1 en-
hances the activity of the RA pathway by increasing RA
synthesis, triggering as a consequence some epigenetic
changes in cooperation with NCor1.
Recent data suggest that Igf1 expression is promoted
by all-trans retinoic acids (ATRA) in epidermal and skel-
etal tissue [51]. In this latter study, variations in the de-
velopmental gene profile were detected in response to a
high-vitamin A (retinol) diet in fish larvae. As a result,
body size and weight were significantly reduced, and
Tgfb1 and RxR were upregulated, along with Igf1 in later
stages of development [51]. In addition, ATRA have a
growth inhibitory effect through upregulation of the c-
Met gene [52]. Since we observed a similar transcription
profile (Additional file 7: Table S2) and phenotype in our
MF model, it could be suggested that epigenetic varia-
tions arising from the RA pathway, among others, in-
duced a different gene expression profile and a reduction
in body weight and size. Remarkably, the findings of other
studies have shown how RA and upregulation of the com-
ponents of the CRABP-II/RA pathway [53] prevent diet-
induced weight gain in mice by inhibiting adipogenesis
in vivo [54]. Related to this, other investigations have de-
termined that besides preventing induced obesity ATRA
also improve glucose intolerance and high SBP. These
transcriptional features mimic what happens in our
model, interestingly, independent of sex (Additional file 7:
Table S2) (Figure 5). Certainly, without considering the in-
fluence of diet, normal, or even improved, levels of glu-
cose tolerance and SBP were obtained in M animals.
Although several other DEGs in these animals could con-
tribute to this behavior, they could all be the consequence
of subsequent global modifications derived from the main
RA branch.
Conclusions
The concept of early life programing is widely accepted,
but for a complete picture of DOHaD we have to under-
stand the different mechanisms of adaptation. Indeed,
our work reveals that a low birth weight is not always an
indicator of intrauterine nutrient restriction, and that it
could be the consequence of stochastic epigenetic vari-
ation. Numerous studies have consistently found evidence
of this stochastic epigenetic variation as the driving force
for developmental and evolutionary adaptation [55-59].
Thus, raised in an identical environment, many loci with
highly variable DNA-methylated regions have been identi-
fied in the liver and brain of newborn isogenic mice, aswell as in the human liver. These loci are associated with
development and morphogenesis, and with the functional
property of expression. Correspondingly, it has been re-
ported that a range of random variability in quantitative
biological traits, for example body weight at 3 months,
may originate from early embryo development [7]. Here
we confirm that phenotypic variation in preimplantation
embryos could be the origin of the random variability of
certain measurable biological traits, such as the natural
variation in birth weight observed in our inbred mice. We
hypothesize that, in early embryos, phenotypic variation is
a strategy aimed at maintaining fitness (reproductive suc-
cess) in a changing environment. This type of adaptive re-
sponse or plasticity is called anticipatory or predictive
adaptation as opposed to immediate adaptation (occurring
in the detrimental Intrauterine Growth Restriction [IUGR]
adaptive response in the fetus) and comes into play be-
cause the early preimplantation embryo lacks the time, or-
gans and/or physiological tools to immediately adjust its
phenotypic development to a new challenging environ-
ment. Sex differences detected between early embryos
could also be related to sex differences in microsomic
adaptation [60,61]. Moreover, we describe here a microso-
mic epigenetic model based on natural embryo variability
that is able to avoid diabetes and/or metabolic syndrome.
Upregulation of the RA pathway (including Crabp-II,
Ppar, Rbp and RxR) together with a putative increase in
the synthesis of its main agonist (RA) via the HOX-PBX1
complex, suggest an epigenetic regulation mechanism
whereby abnormal blood glucose levels, high SBP and
obesity could be prevented or reversed. Hence, it becomes
clear that mammalian early embryos undergo large scale
reprograming of DNA methylation patterns with the po-
tential to create epigenetic diversity among cells and indi-
viduals [62]. This could be important for cell fate decisions
in development and for creating phenotypic diversity in
early embryo development.
Methods
Animal model
All experimental procedures involving mice were approved
by the Ethics Board of the INIA and performed according
to the Guide for the Care and Use of Laboratory Animals
adopted by the Society for the Study of Reproduction and
to European legislation. Mice were fed a standard diet
(Global Diet 2014, Fat 13%, Protein 20% and Carbohy-
drates 67%; Harland Iberica) or high fat diet (from week 6
to 24 of age) (TD.08811 45% kcal Fat Diet (Fat 44,6%, Pro-
tein 14,8% and Carbohydrates 40,6%); Harland Iberia) ad
libitum and kept in a temperature- and light-controlled en-
vironment (22–24°C, 14 L:10D). Adult C57Bl/6 N mice
(Harland) were bred for 2 weeks, and then transferred to
individual cages. Dams delivered naturally, fostered their
own pups, and only litters with 6 to 8 animals were used in
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and upon weaning (Day 20 of life).
Thereafter, weights were recorded each week. Utilizing
standard clinical criteria, microsomia was identified by a
gender-specific weight below the 10th percentile at birth.
For control mice, appropriate growth was defined as a
weight within 1 standard deviation of the colony mean.
For each microsomic mouse detected (36 males and 38
females), the corresponding littermate control mouse was
identified (37 males and 35 females). All study groups
consisted of mice from at least 14 different litters. ICR
(CD-1®) Outbred Mice (Harlan) were used to quantify
birth weight variability in an outbred mouse line. Growth
conditions were similar to those used for the C57BL/6 N
mice, but in this case only litters with 7 to 10 animals were
used in the experiment. To examine the phenotypic re-
sponse to a high-fat diet, mice were fed a normal diet or a
diet rich in lipids from weeks 6 to 24 of age. For the organ
weight, two year old mice were sacrificed and some vis-
cera, including the liver, lung, heart, kidney, spleen, and
testes were excised and accurately weighed. The coeffi-
cients of these organs to body weight were calculated as
the ratio of tissues (wet weight) to body weight.
For experiments of embryo transfer, embryos were
produced using female C57BL/6 N mice aged 6–8 weeks
old. Superovulation was induced with an intraperitoneal
injection of 7.5 IU equine chorionic gonadotropin (eCG,
Folligon, Intervet, Spain), followed 48 h later, by 5 IU of
human chorionic gonadotropin (hCG). Immediately after
hCG administration, females were paired with a male of
the same genetic background in an individual cage over-
night. Morula and blastocysts were collected from the
uterus of females 3 or 4 days after mating. Embryos (10
to 15 per female) were transferred into the uterus of Day
3.5 C57BL/6 N pseudopregnant females [63].
Baseline studies
At 6 months of age, glucose tolerance tests were per-
formed using 10 animals per group. Mice were trans-
ferred to a clean cage and left to fast overnight (16 h)
with ad libitum access to water. The following morning,
the animals underwent a blood glucose tolerance test.
Whole-blood b-D-glucose levels were determined using
a standard handheld glucometer (Glucocard Gsensor,
Arkray Factory, Inc.) on blood samples (2 μl/measure-
ment) collected from the tip of the tail. Following base-
line glucose measurements, the mice were injected i.p.
with glucose (20% solution, 1.5 mg/g). Blood glucose
readings were then taken at 15, 30, 45, 60, and 120 min
postinjection. Food was supplied immediately following
the last measurement. The area under the curve (AUC)
was calculated for plasma glucose (AUCglucose) levels
for the entire 120-min study period according to the
trapezoid rule.For blood pressure measurements, 6 months age mice
were acclimated to restraint and tail-cuff inflation. The
restraint platform was kept at 33–34°C. The mouse was
placed in a metal box restraint with its tail passing
through the optical sensor and compression cuff and
taped to the platform. A traditional tail-cuff occluder
was placed proximally on the mouse’s tail, and the ani-
mal was then immobilized by taping to a V-shaped block
between a light source (above) and a photoresistor (below).
On inflation, the occluder stops blood flow through the
tail, and on deflation return blood flow (RTF) is detected
by the sensor. Amplifier and instrument controls were set
during an initial series of inflation-deflation cycles. This in-
strument (model BP 2000 Blood Pressure Analysis System,
Visitech Systems; Apex, NC) automatically takes 10 30-s
measurements using proprietary software (BP-2000 Soft-
ware BetaVersion 03/10/97). If at least 5 out of 10 readings
were acceptable, the highest and lowest readings were dis-
carded, and the remaining readings were averaged as a sin-
gle session value. Ten animals per experimental group
were used.
Survival curves were constructed for each group of
mice (using the number of animals per group indicated
above) fed or not fed with hfd, according to the Dinse-
Lagakos method [64].
Body length, assessed by the mean of two measure-
ments of nose-to-tail base distance (with five days of
interval), was measured in anaesthetized adult animals
at 30 and 33 weeks of age (for female and male respect-
ively). Body lengths were recorded for 20 animals per
group.
RNA extraction
Livers from each experimental group (normal birth weight
or microsomal littermates) were extracted from newborn
mice. Total RNA was prepared using the TRIzol® Reagent
Kit (Invitrogen) following the manufacturer’s instructions.
Samples were additionally treated with RNeasycolumn
purification kit (QIAGEN) in order to completely remove
genomic DNA. Immediately after extraction, total RNA
was cooled to -80 ºC until further use.
Independent verification of array data by real-time RT-PCR
The RT reaction was carried out according to the manu-
facturer’s instructions (Promega, Madrid, Spain) on 2 μl
of total RNA to generate cDNA. Tubes were heated to
70°C for 5 min to denature the secondary RNA structure
and then the RT mix was completed by the addition of 5
units of Superscript RT enzyme. After incubation at
room temperature for 10 min and then at 42°C for
60 min to allow the reverse transcription of RNA, the
mix was heated at 70°C for 10 min to denature the RT
enzyme. We used 2 μl of cDNA sample in the RT-PCR
mix to detect each transcript.
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qRT-PCR. At least, three replicate PCR experiments
were conducted for all genes of interest. In each sam-
ple, relative levels of each transcript and histone H2az
were compared. PCR was performed by adding a 2-μl
aliquot of each sample to the PCR mix (Quantimix Easy
Sig Kit, Biotools) containing the specific primers. Primer
sequences, annealing temperatures, and the approximate
sizes of the amplified fragments of all transcripts are
shown in (Additional file 8: Table S3). The comparative
cycle threshold (CT) method was used to quantify ex-
pression levels. Quantification was normalized to the
endogenous control H2az. Fluorescence was acquired
in each cycle to determine the threshold cycle or the
cycle during the log-linear phase of the reaction at
which fluorescence increased above background levels
for each sample. Within this region of the amplifica-
tion curve, a difference of one cycle is equivalent to
doubling of the amplified PCR product. According to
the comparative CT method, the CT value was deter-
mined by subtracting the H2az CT value for each sam-
ple from the CT value for each gene. To calculate CT,
the highest sample CT value was used (i.e., the sample
with the lowest target expression) as an arbitrary con-
stant to subtract from all other CT sample values. Fold
changes in relative gene expression of the target were
determined using the formula 2–CT.Statistical analysis
Data processing and statistical tests were performed using
the SigmaStat (Jandel Scientific) package. Differences in
body weight, animal size, glucose levels (in the glucose toler-
ance test) and gene transcription were analyzed by one-way
repeated-measures analysis of variance (ANOVA). When
necessary, percentages and proportions were arcsine-
transformed to normalize data. When main effects were
detected, Holm-Sidak post hoc tests were used for com-
parisons between groups. The trapezoidal rule was used
to determine the AUC of the glucose curves. Mean dif-
ferences were assessed by one-way repeated-measures
ANOVA and significance determined using the Holm-
Sidak post hoc test. Significance was set at P ≤0.05.Microarray analysis
RNA from the liver of newborn mice was purified accord-
ing to standard methods (SI M & M). Samples were amp-
lified, labeled using the Agilent Quick Amp labeling kit,
and hybridized using the Agilent SurePrint G3 Mouse GE
8x60K Microarray (G4852A-028005) (Agilent Technolo-
gies, Palo Alto, CA) and Agilent SureHyb hybridization
chambers. Three independent replicate experiments were
performed for each group. The resulting working gene
lists of transcripts were imported to the Ingenuity® iReportmicroarray analysis program (Ingenuity® Systems) and
FatiGo for gene ontology [19].
Availability of supporting data
Raw data from microarray experiments was submitted to
the Gene Expression Omnibus database (http://www.ncbi.
nlm.nih.gov/geo). The platform ID is GPL13912 and ac-
cession ID is GSE49876.
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